MARKET

GCVRZ

Sanofi FR
GCVRZ
NASDAQ
Delisted
P/E
P/S
P/B
MARKET CAP
0.3341
0.0258
0.0165
1,088,892,353.18
CYTOREASON: MULTI-YEAR AGREEMENT WITH SANOFI VALUED AT UP TO $16 MLN
Reuters · 5h ago
FDA Grants Priority Review to Sanofi's Tzield for Young Children with Type 1 Diabetes
Reuters · 6h ago
Biotech Alveus raises $160 million to tackle weight loss maintenance
Reuters · 1d ago
LIVE MARKETS-Mixed reporting season ahead for European pharma
Reuters · 1d ago
ANALYSIS-Drugmakers brace for Europe pricing fight after Trump's US price-cut deals
Reuters · 1d ago
China Approves Arrowhead’s REDEMPLO for Familial Chylomicronemia Syndrome
Reuters · 2d ago
PRESS DIGEST -Wall Street Journal - January 5
Reuters · 4d ago
FDA Grants Priority Review to Sanofi’s Tzield for Young Children With Type 1 Diabetes
Reuters · 4d ago
More

Webull offers Sanofi FR stock information, including NASDAQ: GCVRZ real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, GCVRZ stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading GCVRZ stock methods without spending real money on the virtual paper trading platform.